Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / American Depositary Shares
-
Shares outstanding
-
5,138,616
-
Total 13F shares
-
16,679
-
Share change
-
+11,096
-
Total reported value
-
$103,485
-
Price per share
-
$6.17
-
Number of holders
-
10
-
Value change
-
+$68,875
-
Number of buys
-
4
-
Number of sells
-
2
Institutional Holders of RedHill Biopharma Ltd. - American Depositary Shares (RDHL) as of Q4 2024
As of 31 Dec 2024,
RedHill Biopharma Ltd. - American Depositary Shares (RDHL) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,679 shares.
The largest 10 holders included
GAMMA Investing LLC, UBS Group AG, Federation des caisses Desjardins du Quebec, MORGAN STANLEY, RHUMBLINE ADVISERS, OSAIC HOLDINGS, INC., GROUP ONE TRADING LLC, SBI Securities Co., Ltd., BANK OF AMERICA CORP /DE/, and Vermillion Wealth Management, Inc..
This page lists
10
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.